FDA announced it has awarded 510(k) clearance for expanded indications of the Masimo O3 Regional Oximetry System to include various delta hemoglobin parameters (ΔcHb, ΔHHb and ΔO 2 Hb) to display ...

The FDA approved a new ketamine (KETARx, PharmaTher) for the treatment of surgical pain management. The FDA previously issued a pair of complete response letters for the application in 2024, citing ...

There remains a need for organizations and stakeholders to develop guidance for prescribing ketamine as a pain treatment.